RESEARCHER PROFILE

Michael Shapi

← Back to Mangosuthu University of Technology

M

Mangosuthu University of Technology

Computational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchHeavy metals in environmentSynthesis and biological activitySynthesis and Characterization of Heterocyclic Compounds

Michael Shapi works in Computational Drug Discovery Methods, SARS-CoV-2 and COVID-19 Research, Heavy metals in environment, Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds. Recorded institutional associations include Mangosuthu University of Technology.

20Publications
661Citations
10H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. A Review of the Recent Development in the Synthesis and Biological Evaluations of Pyrazole Derivatives

    2022 · 201 citations
  2. An Overview of the Biological Evaluation of Selected Nitrogen-Containing Heterocycle Medicinal Chemistry Compounds

    2022 · 184 citations
  3. Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz

    2020 · 72 citations
  4. A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization

    2022 · 45 citations
  5. Amide imidic prototropic tautomerization of efavirenz, NBO analysis, hyperpolarizability, polarizability and HOMO–LUMO calculations using density functional theory

    2021 · 24 citations
  6. Mapping Scientific Productivity Trends and Hotspots in Remdesivir Research Publications: A Bibliometric Study from 2016 to 2021

    2022 · 23 citations
  7. Discovery of Potential Inhibitors for RNA-Dependent RNA Polymerase of Norovirus: Virtual Screening, and Molecular Dynamics

    2020 · 16 citations
  8. Background Concentrations of Potentially Harmful Elements in Soils of the Kette-Batouri Region, Eastern Cameroon

    2016 · 14 citations
  9. Unveiling of Pyrimidindinones as Potential Anti-Norovirus Agents—A Pharmacoinformatic-Based Approach

    2022 · 13 citations
  10. Investigation of the solvent-dependent photolysis of a nonnucleoside reverse-transcriptase inhibitor, antiviral agent efavirenz

    2017 · 10 citations
  11. Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis

    2021 · 10 citations
  12. Occurrence and levels of potentially harmful elements (PHEs) in natural waters of the gold mining areas of the Kette-Batouri region of Eastern Cameroon

    2018 · 9 citations
  13. Analysis of the Distribution of Some Potentially Harmful Elements (PHEs) in the Krugersdorp Game Reserve, Gauteng, South Africa

    2020 · 9 citations
  14. Determination of Potentially Harmful Element (PHE) Distribution in Water Bodies in Krugersdorp, a Mining City in the West Rand, Gauteng Province, South Africa

    2021 · 9 citations
  15. Predicting New Anti-Norovirus Inhibitor With the Help of Machine Learning Algorithms and Molecular Dynamics Simulation–Based Model

    2021 · 9 citations
  16. A Molecular Docking Study Reveals That Short Peptides Induce Conformational Changes in the Structure of Human Tubulin Isotypes αβI, αβII, αβIII and αβIV

    2023 · 6 citations
  17. Potential SARS-COV preclinical (in vivo) compounds targeting COVID-19 main protease: a meta-analysis and molecular docking studies.

    2021 · 5 citations
  18. Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification

    2021 · 3 citations
  19. Identification of SARS-CoV-2 preclinical (in vivo) compounds targeting COVID-19 main protease: A scoping review, meta-analysis and molecular docking studies

    2020 · 1 citations
  20. Formulation and Solid-State Characterisation of a Novel Benzanilide Co-crystal of the Anti-HIV Drug Efavirenz

    2018 · 0 citations

← Return to the university profile